Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
Thomas Gentinetta, John D. Belcher, Valérie Brügger‐Verdon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 630-630
Open Access | Times Cited: 25

Showing 25 citing articles:

Understanding mechanisms of antioxidant action in health and disease
Barry Halliwell
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 1, pp. 13-33
Closed Access | Times Cited: 237
Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics
Florence Vallelian, Paul W. Buehler, Dominik J. Schaer
Blood (2022) Vol. 140, Iss. 17, pp. 1837-1844
Open Access | Times Cited: 78
A review on disease modifying pharmacologic therapies for sickle cell disease
Himil Mahadevia, Ben Ponvilawan, Ujjwal Madan, et al.
Annals of Hematology (2025)
Open Access | Times Cited: 1
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi
Blood (2024) Vol. 144, Iss. 8, pp. 853-866
Open Access | Times Cited: 7
New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia
Alan Zanardi, Ilaria Nardini, Sara Raia, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
The clinical relevance of heme detoxification by the macrophage heme oxygenase system
Scott Yeudall, Clint Upchurch, Norbert Leitinger
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation—A Short Review
Athena Starlard‐Davenport, Chithra D. Palani, Xingguo Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4192-4192
Open Access
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
Alexandra Gerogianni, Jordan D. Dimitrov, Alessandra Zarantonello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions
Suruchi Salgar, Beatriz E. Bolívar, Jonathan M. Flanagan, et al.
Translational research (2022) Vol. 252, pp. 34-44
Open Access | Times Cited: 14
Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship
Rayan Bou‐Fakhredin, Lucia De Franceschi, Irene Motta, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 967-967
Open Access | Times Cited: 12
Targeting heme in sickle cell disease: new perspectives on priapism treatment
Tammyris Helena Rebecchi Silveira, Fabiano Beraldi Calmasini, Mariana Gonçalves de Oliveira, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease
Joan D. Beckman, Erica Sparkenbaugh
Current Opinion in Hematology (2023) Vol. 30, Iss. 5, pp. 153-158
Closed Access | Times Cited: 6
Lactate dehydrogenase and hemolysis index to predict vaso-occlusive crisis in sickle cell disease
Guillaume Feugray, Cécile Dumesnil, Maximilien Grall, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
The ‘scintilla’ starting vaso‐occlusion in sickle cell disease
Andrea Piccin, Ibrahim Magzoub, Tor Hervig
British Journal of Haematology (2023) Vol. 201, Iss. 3, pp. 379-380
Open Access | Times Cited: 4
Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches
Érica M.F. Gotardo, Pâmela L. Brito, Lucas Fernando Sérgio Gushiken, et al.
Vascular Pharmacology (2023) Vol. 150, pp. 107176-107176
Closed Access | Times Cited: 4
Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease
Madhav Vissa, Sandra Larkin, Elliott Vichinsky, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 10, pp. 897-907
Open Access | Times Cited: 2
A method for detection of anti-drug antibodies to a biotherapeutic (CSL112) with endogenous counterpart (apolipoprotein A-I) using a novel sample pre-treatment electrochemiluminescence assay
Roslyn Davis, Elena Velkoska, Helen McCallum, et al.
Journal of Immunological Methods (2022) Vol. 513, pp. 113411-113411
Open Access | Times Cited: 3
Navigating Hemolysis, Hemoglobin Toxicity, and Its Renal Implications in Cardiac Surgery
Dominik J. Schaer, Christian A. Schaer, Rok Humar, et al.
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1162-1174
Closed Access
Hemopexin alleviates sterile inflammation in ischemia-reperfusion-induced lung injury
Tomoyuki Nakagiri, N. Köhler, Sabina Janciauskiene, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Mitigating hemoglobin‐induced nephropathy: ApoHb‐hp protection of podocytes
Daniela Lucas, Carlos Muñoz, Quintin O’Boyle, et al.
Physiological Reports (2024) Vol. 12, Iss. 22
Open Access
Accelerated atherosclerosis in beta-thalassemia
Julian Hurtado, Hassan Sellak, Giji Joseph, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 325, Iss. 5, pp. H1133-H1143
Closed Access | Times Cited: 1
Double-edged functions of hemopexin in hematological related diseases: from basic mechanisms to clinical application
Yijin Li, Renyu Chen, Chaofan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Induction of p16Ink4a Gene Expression in Heme Protein–Induced AKI and by Heme: Pathophysiologic Implications
Karl A. Nath, Raman Deep Singh, Anthony J. Croatt, et al.
Kidney360 (2024) Vol. 5, Iss. 4, pp. 501-514
Open Access
The Current State of Sickle Cell Disease Treatments [Part I]
Anjali A. Sarkar
GEN Biotechnology (2022) Vol. 1, Iss. 6, pp. 465-471
Closed Access | Times Cited: 1
The role of the thromboinflammatory response under hemolytic conditions: pathophysiological mechanisms and therapeutic inhibition
Alexandra Gerogianni
(2023)
Open Access
Page 1

Scroll to top